Presented by Robert G. Stern, MD
Geriatric Psychiatrist
Jersey Shore University Medical Center, Division of Geriatric Psychiatry

Several prescription drugs have been available to treat the symptoms of Alzheimer’s disease for many years. In the past 2 years, the U.S. Food and Drug Administration (FDA) has given full approval to disease-modifying drugs. These medications are called disease-modifying drugs because they work by targeting and clearing beta-amyloid plaques from the brain.

In our upcoming guest speaker webinar, Robert G. Stern, MD, will discuss current FDA-approved medications for the treatment of Alzheimer’s disease. Dr. Stern will also describe common behavior disturbances that may occur with Alzheimer’s disease and typical pharmacological interventions. Dr. Stern will also review the importance of clinical trials in Alzheimer’s disease research.